The company will use the funds for its U.S. market launch of its FDA-approved Odne Cure and Odne Fill products for root preservation therapy, according to a March 13 news release from Odne.
The company recently founded Odne Inc, USA and appointed Jeff Durrbeck as president of U.S. operations to serve the endodontics market in the states.
The investment round was led by Revere Partner and NV Capital, the release said.